Silverback Therapeutics, Inc. (NASDAQ:SBTX – Get Free Report) shares hit a new 52-week high during trading on Tuesday . The company traded as high as $14.05 and last traded at $13.96, with a volume of 1134132 shares changing hands. The stock had previously closed at $13.20.
Silverback Therapeutics Stock Performance
The company has a market cap of $468.03 million, a price-to-earnings ratio of -5.77 and a beta of 0.60. The company has a fifty day moving average of $10.71 and a two-hundred day moving average of $9.46.
Silverback Therapeutics Company Profile
Silverback Therapeutics, Inc, a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver.
Read More
- Five stocks we like better than Silverback Therapeutics
- Best Stocks Under $5.00
- Does A&F’s Q2 Earnings Win Point to a Strong Holiday Season?
- Market Cap Calculator: How to Calculate Market Cap
- Best Buy Stock Flashes Bullish Signal, Challenges Remain
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Affirm Shows Buy-Now-Pay-Later Is Here to Stay in Latest Results
Receive News & Ratings for Silverback Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silverback Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
